Needham 23rd Annual Virtual Healthcare Conference
Steven Kelly , President and Chief Executive Officer, will give a corporate presentation.Wednesday, April 10 at3:45 PM ET - Virtual
Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit
Steven Kelly , President and Chief Executive Officer, will give a corporate presentation.Monday, April 29 at2:00 PM ET - Virtual
Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following each event.
About Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in
Investors:
Head of Investor Relations
investors@carismatx.com
Media Contact:
(763) 350-5223
jstern@realchemistry.com
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.